Brenner, Darren M. http://orcid.org/0000-0002-8577-7278
Slatkin, Neal E. http://orcid.org/0000-0002-4389-7343
Stambler, Nancy
Israel, Robert J. http://orcid.org/0000-0002-4150-2336
Coluzzi, Paul H.
Funding for this research was provided by:
Salix Pharmaceuticals, a division of Bausch Health US, LLC
Article History
Received: 11 October 2020
Accepted: 9 February 2021
First Online: 25 February 2021
Declarations
:
: Each study site obtained institutional review board and independent ethics committee approval for the protocols and informed consent forms. Each study was conducted in compliance with the principals of Good Clinical Practice and in accordance with the Declaration of Helsinki.
: All study participants provided written informed consent.
: NA
: Dr. Brenner is a consultant, advisor, and speaker for Salix Pharmaceuticals. His research is also supported by an unrestricted gift from the Irene D. Pritzker Foundation.Dr. Slatkin is an employee of Salix Pharmaceuticals, a subsidiary of Bausch Health US, LLC.Dr. Stambler is a full-time employee and shareholder of Progenics Pharmaceuticals, Inc., a subsidiary of Lantheus Holdings, Inc.Dr. Israel is an employee of Bausch Health US, LLC.Dr. Coluzzi is a full-time employee of the University of California, Irvine.